LXRX logo

LXRX
Lexicon Pharmaceuticals Inc

13,641
Mkt Cap
$619.31M
Volume
1.39M
52W High
$1.83
52W Low
$0.2976
PE Ratio
-8.23
LXRX Fundamentals
Price
$1.59
Prev Close
$1.56
Open
$1.50
50D MA
$1.32
Beta
1.72
Avg. Volume
2.5M
EPS (Annual)
-$0.6262
P/B
4.72
Rev/Employee
$301,757.28
$104.46
Loading...
Loading...
News
all
press releases
Lexicon Pharmaceuticals (NASDAQ:LXRX) Director Acquires $147,000.00 in Stock
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX - Get Free Report) Director Raymond Debbane bought 100,000 shares of Lexicon Pharmaceuticals stock in a transaction that occurred on Monday, February 23rd...
MarketBeat·5d ago
News Placeholder
More News
News Placeholder
Lexicon Pharmaceuticals (LXRX) Projected to Post Earnings on Thursday
Lexicon Pharmaceuticals (NASDAQ:LXRX) will be releasing its Q4 2025 earnings before the market opens on Thursday, March 5. (View Earnings Report at...
MarketBeat·5d ago
News Placeholder
Lexicon Pharmaceuticals (NASDAQ:LXRX) Director Raymond Debbane Acquires 100,000 Shares
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX - Get Free Report) Director Raymond Debbane purchased 100,000 shares of the stock in a transaction that occurred on Monday, February 23rd. The stock was...
MarketBeat·6d ago
News Placeholder
Lexicon Pharmaceuticals (NASDAQ:LXRX) Director Raymond Debbane Buys 100,000 Shares
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX - Get Free Report) Director Raymond Debbane purchased 100,000 shares of the firm's stock in a transaction dated Friday, February 20th. The shares were...
MarketBeat·7d ago
News Placeholder
Lexicon Pharmaceuticals (NASDAQ:LXRX) Director Buys $72,000.00 in Stock
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX - Get Free Report) Director Raymond Debbane purchased 50,000 shares of the business's stock in a transaction that occurred on Thursday, February 19th. The...
MarketBeat·8d ago
News Placeholder
Insider Buying: Lexicon Pharmaceuticals (NASDAQ:LXRX) Director Purchases 100,000 Shares of Stock
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX - Get Free Report) Director Raymond Debbane purchased 100,000 shares of Lexicon Pharmaceuticals stock in a transaction on Friday, February 20th. The shares...
MarketBeat·8d ago
News Placeholder
Lexicon Pharmaceuticals (NASDAQ:LXRX) Shares Gap Up - Here's What Happened
Lexicon Pharmaceuticals (NASDAQ:LXRX) Shares Gap Up - Time to Buy...
MarketBeat·12d ago
News Placeholder
GSA Capital Partners LLP Sells 1,627,753 Shares of Lexicon Pharmaceuticals, Inc. $LXRX
GSA Capital Partners LLP lessened its stake in shares of Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX - Free Report) by 57.5% in the third quarter, according to its most recent filing with the...
MarketBeat·13d ago
News Placeholder
Invus Global Management, Llc Purchases 1,538,462 Shares of Lexicon Pharmaceuticals (NASDAQ:LXRX) Stock
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX - Get Free Report) Director Invus Global Management, Llc purchased 1,538,462 shares of the business's stock in a transaction dated Monday, February 2nd. The...
MarketBeat·26d ago
News Placeholder
Apellis Pharmaceuticals (APLS) Surges 5.8%: Is This an Indication of Further Gains?
Apellis Pharmaceuticals (APLS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
Zacks·1mo ago
<
1
2
...
>

Latest LXRX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.